Limited detectability of linezolid-resistant Staphylococcus aureus by the Etest method and its improvement using enriched media

References

1. Arias C. A., Vallejo M., Reyes J., Panesso D., Moreno J., Castañeda E., Villegas M. V., Murray B. E., Quinn J. P. 2008; Clinical and microbiological aspects of linezolid resistance mediated by the cfr gene encoding a 23S rRNA methyltransferase. J Clin Microbiol 46:892–896 [View Article][PubMed]
   [Google Scholar]
2. Bozdogan B., Appelbaum P. C. 2004; Oxazolidinones: activity, mode of action, and mechanism of resistance. Int J Antimicrob Agents 23:113–119 [View Article][PubMed]
   [Google Scholar]
3. CLSI 2007; Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria that Grow Aerobically; Approved Standard. M7-A7. Wayne, PA: Clinical and Laboratory Standards Institute;
4. Gómez-Garcés J. L., López-Fabal F., Burillo A., Gil Y. 2010; [Comparative study of the susceptibility to daptomycin and other antimicrobials against Staphylococcus spp. resistant to methicillin and Enterococcus spp. using Wider, E-test, and microdilution methods]. Rev Esp Quimioter 23:87–92 (in Spanish) [PubMed]
   [Google Scholar]
5. Ikeda-Dantsuji Y., Hanaki H., Nakae T., Takesue Y., Tomono K., Honda J., Yanagihara K., Mikamo H., Fukuchi K. other authors 2011a; Emergence of linezolid-resistant mutants in a susceptible-cell population of methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother 55:2466–2468 [View Article][PubMed]
   [Google Scholar]
6. Ikeda-Dantsuji Y., Hanaki H., Sakai F., Tomono K., Takesue Y., Honda J., Nonomiya Y., Suwabe A., Nagura O. other authors 2011b; Linezolid-resistant Staphylococcus aureus isolated from 2006 through 2008 at six hospitals in Japan. J Infect Chemother 17:45–51 [View Article][PubMed]
   [Google Scholar]
7. Locke J. B., Hilgers M., Shaw K. J. 2009; Novel ribosomal mutations in Staphylococcus aureus strains identified through selection with the oxazolidinones linezolid and torezolid (TR-700). Antimicrob Agents Chemother 53:5265–5274 [View Article][PubMed]
   [Google Scholar]
8. Meka V. G., Gold H. S. 2004; Antimicrobial resistance to linezolid. Clin Infect Dis 39:1010–1015 [View Article][PubMed]
   [Google Scholar]
9. Meka V. G., Pillai S. K., Sakoulas G., Wennersten C., Venkataraman L., DeGirolami P. C., Eliopoulos G. M., Moellering R. C. Jr, Gold H. S. 2004; Linezolid resistance in sequential Staphylococcus aureus isolates associated with a T2500A mutation in the 23S rRNA gene and loss of a single copy of rRNA. J Infect Dis 190:311–317 [View Article][PubMed]
   [Google Scholar]
10. Shinabarger D. 1999; Mechanism of action of the oxazolidinone antibacterial agents. Expert Opin Investig Drugs 8:1195–1202 [View Article][PubMed]
    [Google Scholar]
11. Tenover F. C., Williams P. P., Stocker S., Thompson A., Clark L. A., Limbago B., Carey R. B., Poppe S. M., Shinabarger D., McGowan J. E. Jr 2007; Accuracy of six antimicrobial susceptibility methods for testing linezolid against staphylococci and enterococci. J Clin Microbiol 45:2917–2922 [View Article][PubMed]
    [Google Scholar]
12. Tsiodras S., Gold H. S., Sakoulas G., Eliopoulos G. M., Wennersten C., Venkataraman L., Moellering R. C. Jr, Ferraro M. J. 2001; Linezolid resistance in a clinical isolate of Staphylococcus aureus. Lancet 358:207–208 [View Article][PubMed]
    [Google Scholar]
13. Tubau F., Fernández-Roblas R., Liñares J., Martín R., Soriano F. 2001; In vitro activity of linezolid and 11 other antimicrobials against 566 clinical isolates and comparison between NCCLS microdilution and Etest methods. J Antimicrob Chemother 47:675–680 [View Article][PubMed]
    [Google Scholar]